Literature DB >> 28656286

MicroRNA-497 upregulation inhibits cell invasion and metastasis in T24 and BIU-87 bladder cancer cells.

Zhiyong Wei1, Xiaofeng Hu2, Junjie Liu3, Wenbin Zhu4, Xuemei Zhan1, Shuhong Sun2.   

Abstract

Previous studies have reported the crucial role of microRNAs (miRNAs) in the biology and tumorigenesis of various types of cancer, including bladder cancer. The present study aimed to investigate the importance of miRNA (miR)‑497 on the pathogenesis of bladder cancer. A total of 50 patients diagnosed with bladder cancer were enrolled in the current study. The expression levels of miR‑497 in the cancerous and the adjacent noncancerous tissues were detected using reverse transcription‑quantitative polymerase chain reaction. The association between miR‑497 expression and various parameters, including age, tumor‑node‑metastasis (TNM) stage and pathological classification was determined. An miR‑497‑overexpressing vector was transfected into the T24 and BIU‑87 bladder cancer cell lines in order to determine the effect of miR‑497 expression on cell migration and invasion using Transwell assays. Additionally, the cell migration and invasion‑associated protein expression levels were also analyzed using western blotting. The findings of the present study revealed that miR‑497 was expressed at low levels in the cancer bladder tissue compared with the adjacent noncancerous tissue, and its expression was associated with the pathological classification, TNM stage and metastasis. Additionally, miR‑497 overexpression significantly reduced the number of migrated and invasive T24 and BIU‑87 cells. The mRNA and protein expression levels of E‑cadherin were increased, whereas levels of vimentin and α‑smooth muscle actin were reduced following miR‑497 overexpression. The present study revealed that miR‑497 overexpression may be a suppressor of the metastasis of bladder cancer, and may have an important role in the diagnosis of bladder cancer.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28656286     DOI: 10.3892/mmr.2017.6805

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  7 in total

1.  G-Quadruplexes influence pri-microRNA processing.

Authors:  Samuel G Rouleau; Jean-Michel Garant; François Bolduc; Martin Bisaillon; Jean-Pierre Perreault
Journal:  RNA Biol       Date:  2017-12-11       Impact factor: 4.652

Review 2.  MicroRNAs: Key Players in Bladder Cancer.

Authors:  Qi Li; Helei Wang; Hourong Peng; Qiuping Huang; Ting Huyan; Qingsheng Huang; Hui Yang; Junling Shi
Journal:  Mol Diagn Ther       Date:  2019-10       Impact factor: 4.074

3.  Tumor-suppressing effects of microRNA-612 in bladder cancer cells by targeting malic enzyme 1 expression.

Authors:  Mengnan Liu; Yifan Chen; Bisheng Huang; Shiyu Mao; Keke Cai; Longsheng Wang; Xudong Yao
Journal:  Int J Oncol       Date:  2018-03-29       Impact factor: 5.650

4.  Biological relevance and therapeutic potential of G-quadruplex structures in the human noncoding transcriptome.

Authors:  Martina Tassinari; Sara N Richter; Paolo Gandellini
Journal:  Nucleic Acids Res       Date:  2021-04-19       Impact factor: 16.971

Review 5.  Emerging Biomarkers for Predicting Bladder Cancer Lymph Node Metastasis.

Authors:  Chunyu Zhang; Jiao Hu; Huihuang Li; Hongzhi Ma; Belaydi Othmane; Wenbiao Ren; Zhenglin Yi; Dongxu Qiu; Zhenyu Ou; Jinbo Chen; Xiongbing Zu
Journal:  Front Oncol       Date:  2021-03-19       Impact factor: 6.244

6.  miR‑497/MIR497HG inhibits glioma cell proliferation by targeting CCNE1 and the miR‑588/TUSC1 axis.

Authors:  Li-Ya Ji; Ming Wei; Yuan-Yuan Liu; Zheng-Li Di; San-Zhong Li
Journal:  Oncol Rep       Date:  2021-10-19       Impact factor: 3.906

7.  miR-497 may enhance the sensitivity of non-small cell lung cancer cells to gefitinib through targeting the insulin-like growth factor-1 receptor.

Authors:  Wei Ma; Weiye Feng; Jie Tan; Airu Xu; Yudong Hu; Lanlan Ning; Yanhong Kang; Liuqian Wang; Ziwen Zhao
Journal:  J Thorac Dis       Date:  2018-10       Impact factor: 2.895

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.